Items where authors include "Adam, F."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099
Okwuwa, C.C., Adam, F. and Ries, M.E. orcid.org/0000-0002-8050-3200 (2025) Nanocellulose dissolution in green solvents: Enhancing carrageenan biocomposites for sustainable hard capsule production. Cellulose. ISSN 0969-0239
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. EClinicalMedicine, 81. 103080. ISSN 2589-5370
Ramli, N.A., Adam, F., Ries, M.E. orcid.org/0000-0002-8050-3200 et al. (1 more author) (2024) DES-ultrasonication treatment of cellulose nanocrystals and the reinforcement in carrageenan biocomposite. International Journal of Biological Macromolecules, 270 (Part 2). 132385. ISSN 0141-8130
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Okwuwa, C.C. orcid.org/0009-0000-6264-8695, Adam, F., Mohd Said, F. orcid.org/0000-0003-0737-3486 et al. (1 more author) (2023) Cellulose dissolution for edible biocomposites in deep eutectic solvents: A review. Journal of Cleaner Production, 427. 139166. ISSN 0959-6526
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Ramli, N.A., Adam, F., Mohd Amin, K.N. et al. (2 more authors) (2023) Mechanical and Thermal Evaluation of Carrageenan/Hydroxypropyl Methyl Cellulose Biocomposite Incorporated with Modified Starch Corroborated by Molecular Interaction Recognition. ACS Applied Polymer Materials, 5 (1). pp. 182-192. ISSN 2637-6105
Shahrir, N., Anuar, N. orcid.org/0000-0003-4003-0194, Abdul Muttalib, N.A. et al. (4 more authors) (2022) The Role of Solvent Hydroxyl Functional Groups on the Interaction Energy and Growth of Form I Paracetamol Crystal Facets. Organic Process Research and Development, 26 (12). pp. 3226-3235. ISSN 1083-6160